KRAS and neoplasm: In the transgenic pancreatic ductal adenocarcinoma mouse model, Cre expression under a pancreas-specific promoter activates expression of the mutant tumor-driving genes Kras(G12D) and Tp53(R172H), leading to progressive carcinogenesis from pancreatic intraepithelial neoplasia [4].